{"id":"pregabalin-add-on-therapy","safety":{"commonSideEffects":[{"rate":"20–30%","effect":"Dizziness"},{"rate":"15–25%","effect":"Somnolence"},{"rate":"5–10%","effect":"Dry mouth"},{"rate":"5–10%","effect":"Edema"},{"rate":"5–10%","effect":"Weight gain"},{"rate":"5–10%","effect":"Blurred vision"},{"rate":"5–10%","effect":"Ataxia"}]},"_chembl":{"chemblId":"CHEMBL1059","moleculeType":"Small molecule","molecularWeight":"159.23"},"_dailymed":null,"mechanism":{"_ai_source":"anthropic-haiku","explanation":"Pregabalin is a gabapentinoid that decreases calcium influx into nerve terminals by binding to the alpha-2-delta-1 subunit of presynaptic voltage-gated calcium channels. This reduces the release of neurotransmitters such as glutamate, noradrenaline, and substance P, thereby dampening neuronal hyperexcitability. As add-on therapy, it enhances the efficacy of other treatments in conditions characterized by neuropathic pain or seizure activity.","oneSentence":"Pregabalin binds to the alpha-2-delta subunit of voltage-gated calcium channels in the central nervous system, reducing the release of excitatory neurotransmitters.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:51:53.076Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Neuropathic pain (add-on therapy)"},{"name":"Partial-onset seizures (add-on therapy)"},{"name":"Generalized anxiety disorder (add-on therapy)"}]},"trialDetails":[{"nctId":"NCT07495943","phase":"NA","title":"Effects of 2-Aticyto Complex and D-Ribose on Pain and Clinical Course in Patients With Fibromyalgia","status":"NOT_YET_RECRUITING","sponsor":"Haydarpasa Numune Training and Research Hospital","startDate":"2026-05-04","conditions":"Fibromyalgia Syndrome, Fibromyalgia","enrollment":200},{"nctId":"NCT07230171","phase":"NA","title":"The Efficacy and Safety of Short Term S-ketamine Infusion as an Adjunctive Therapy in Patients With Fibromyalgia","status":"RECRUITING","sponsor":"Beijing Tiantan Hospital","startDate":"2025-09-15","conditions":"Fibromyalgia, Pregabalin, Esketamine","enrollment":106},{"nctId":"NCT07348952","phase":"NA","title":"Different Transcutaneous Electrical Nerve Stimulation Modes in Pudendal Neuralgia Post-prostatectomy","status":"COMPLETED","sponsor":"Cairo University","startDate":"2023-09-01","conditions":"Transcutaneous Electrical Nerve Stimulation, Pudendal Neuralgia, Post Prostatectomy","enrollment":60},{"nctId":"NCT06672419","phase":"NA","title":"Effectiveness of AI-Guided Exercise and Pain Neuroscience Education for Fibromyalgia (FIBROIA)","status":"NOT_YET_RECRUITING","sponsor":"Instituto Neurociencia Del Dolor","startDate":"2026-02-01","conditions":"Fibromyalgia, Fibromyalgia Syndrome","enrollment":50},{"nctId":"NCT07313111","phase":"PHASE4","title":"Thymoquinone as an add-on Therapy for the Management of Patients With Diabetic Peripheral Neuropathy","status":"COMPLETED","sponsor":"Hawler Medical University","startDate":"2024-07-01","conditions":"Diabetic Peripheral Neuropathy (DPN)","enrollment":50},{"nctId":"NCT07296770","phase":"PHASE3","title":"An Artificial Intelligence Driven Approach to Optimize Patient Selection for a Transitional Pain Service","status":"NOT_YET_RECRUITING","sponsor":"University of California, San Francisco","startDate":"2026-05-01","conditions":"Postsurgical Pain Management, Postsurgical Pain, Chronic, Opioid Use After Surgery","enrollment":126},{"nctId":"NCT07084753","phase":"NA","title":"Non-opioid Anesthesia Based on Thoracic Paravertebral Block During Laparoscopic Sleeve Gastrectomy","status":"NOT_YET_RECRUITING","sponsor":"IVO JURISIC","startDate":"2025-07-30","conditions":"Obese Patients, Bariatric Surgical Pain, Bariatric Surgery (Sleeve Gastrectomy )","enrollment":36},{"nctId":"NCT03913819","phase":"","title":"Treatment Outcomes Under a Standardized Treatment Protocol in Patients Suffered Substance Abuse Related Voiding Dysfunction","status":"RECRUITING","sponsor":"Chinese University of Hong Kong","startDate":"2011-12-10","conditions":"Voiding Dysfunction, Substance Abuse","enrollment":1000},{"nctId":"NCT06896994","phase":"NA","title":"Esketamine Combined Pregabalin and Duloxetine for Postherpetic Neuralgia","status":"RECRUITING","sponsor":"Beijing Tiantan Hospital","startDate":"2025-04-01","conditions":"Postherpetic Neuralgia","enrollment":150},{"nctId":"NCT06914180","phase":"NA","title":"Esketamine Combined With PRF for Trigeminal Postherpetic Neuralgia","status":"NOT_YET_RECRUITING","sponsor":"Beijing Tiantan Hospital","startDate":"2025-04-01","conditions":"Postherpetic; Neuralgia, Trigeminal (Etiology)","enrollment":174},{"nctId":"NCT06914193","phase":"NA","title":"Esketamine Combined With PRF of DRG for Postherpetic Neuralgia","status":"NOT_YET_RECRUITING","sponsor":"Beijing Tiantan Hospital","startDate":"2025-04-01","conditions":"Postherpetic Neuralgia","enrollment":186},{"nctId":"NCT04894864","phase":"PHASE4","title":"Opioid Free Anesthesia-Analgesia Strategy and Surgical Stress in Elective Open Abdominal Aortic Aneurysm Repair","status":"RECRUITING","sponsor":"University of Crete","startDate":"2020-10-08","conditions":"Elective Surgical Procedures, Postoperative Pain, Anesthesia","enrollment":40},{"nctId":"NCT06488586","phase":"","title":"IV Ketamine Vs. in Esketamine for MDD TRD","status":"RECRUITING","sponsor":"Gustavo Vazquez","startDate":"2023-03-20","conditions":"Treatment Resistant Depression","enrollment":80},{"nctId":"NCT06357260","phase":"NA","title":"Pregabalin as an add-on Therapy to Carbamazepine in Trigeminal Neuralgia Patients","status":"RECRUITING","sponsor":"Postgraduate Institute of Dental Sciences Rohtak","startDate":"2024-04-01","conditions":"Trigeminal Neuralgia","enrollment":50},{"nctId":"NCT05172739","phase":"PHASE4","title":"Opioid Free Anaesthesia-Analgesia Strategy on Surgical Stress and Immunomodulation in Elective VATS-Lobectomy for NSCLC","status":"RECRUITING","sponsor":"University of Crete","startDate":"2021-10-01","conditions":"Systemic Inflammatory Response Syndrome, Postoperative Pain, Acute, Postoperative Pain, Chronic","enrollment":70},{"nctId":"NCT04546334","phase":"NA","title":"Erector Spinae Plane Block in Post-herpetic Neuralgia","status":"COMPLETED","sponsor":"Tanta University","startDate":"2020-09-26","conditions":"Postherpetic Neuralgia","enrollment":90},{"nctId":"NCT00143130","phase":"PHASE3","title":"Pregabalin In Partial Seizures Extension Study","status":"COMPLETED","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","startDate":"2005-04","conditions":"Seizures","enrollment":227},{"nctId":"NCT00372528","phase":"PHASE3","title":"An Open-Label Study Of Pregabalin In Subjects With Refractory Partial Seizures","status":"TERMINATED","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","startDate":"2007-03","conditions":"Epilepsy","enrollment":21},{"nctId":"NCT00407797","phase":"PHASE4","title":"Pregabalin In Partial Seizures (PREPS): An Open-Label, Multicenter Add On Therapy Trial","status":"TERMINATED","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","startDate":"2007-03","conditions":"Partial Seizures","enrollment":136},{"nctId":"NCT00141427","phase":"PHASE4","title":"Pregabalin In Partial Seizures: An Open-Label, International, Multicenter Add-On Therapy Trial.","status":"COMPLETED","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","startDate":"2004-11","conditions":"Seizures","enrollment":540},{"nctId":"NCT01220180","phase":"","title":"Lyrica (Pregabalin) Korean Post Marketing Surveillance Study","status":"COMPLETED","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","startDate":"2006-07","conditions":"Epilepsy, Neuropathic Pain, Fibromyalgia","enrollment":4175},{"nctId":"NCT00288639","phase":"PHASE4","title":"Lyrica (Pregabalin) Administered as an Add-on Therapy for Partial Seizures (LEADER).","status":"COMPLETED","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","startDate":"2005-12","conditions":"Epilepsy","enrollment":98},{"nctId":"NCT01389596","phase":"PHASE3","title":"A Study of the Efficacy and Safety of Pregabalin as Add-On Therapy for Partial Onset Seizures in Children Ages 4-16 Years","status":"COMPLETED","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","startDate":"2011-09-27","conditions":"Epilepsy, Partial Seizures","enrollment":295},{"nctId":"NCT01463306","phase":"PHASE3","title":"A 12-Month Study To Evaluate The Safety And Tolerability Of Pregabalin As Add-On Therapy In Pediatric Subjects 1 Month To 16 Years Of Age With Partial Onset Seizures And Pediatric And Adult Subjects 5 To 65 Years Of Age With Primary Generalized Tonic-Clonic Seizures","status":"COMPLETED","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","startDate":"2012-02-21","conditions":"Epilepsy, Partial Seizures, Epilepsy, Primary Generalized Tonic-Clonic Seizures","enrollment":605},{"nctId":"NCT02072824","phase":"PHASE3","title":"A Safety, Efficacy, and Tolerability Trial of Pregabalin as Add-On Treatment in Pediatric Subjects <4 Years of Age With Partial Onset Seizures.","status":"COMPLETED","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","startDate":"2014-09-16","conditions":"Partial Onset Seizures","enrollment":175},{"nctId":"NCT01747915","phase":"PHASE3","title":"A Safety, Efficacy and Tolerability Trial of Pregabalin as Add-On Treatment in Pediatric and Adult Subjects With Primary Generalized Tonic-Clonic (i.e., Grand Mal) Seizures.","status":"COMPLETED","sponsor":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","startDate":"2013-04-03","conditions":"Generalized Tonic Clonic Seizures","enrollment":219},{"nctId":"NCT04689984","phase":"PHASE2, PHASE3","title":"The Benefits of Astaxanthin as Add on Therapy in the Management of Painful Diabetic Neuropathy Patient","status":"UNKNOWN","sponsor":"Duta Wacana Christian University","startDate":"2020-11-03","conditions":"Painful Diabetic Neuropathy","enrollment":60},{"nctId":"NCT04689971","phase":"PHASE2, PHASE3","title":"The Benefits of Vitamin B Combination as Add on Therapy in the Management of Painful Diabetic Neuropathy Patient","status":"UNKNOWN","sponsor":"Duta Wacana Christian University","startDate":"2020-11-03","conditions":"Painful Diabetic Neuropathy","enrollment":60},{"nctId":"NCT04689958","phase":"PHASE2, PHASE3","title":"The Benefits of Vitamin D 5000 IU as Add on Therapy in the Management of Painful Diabetic Neuropathy Patient","status":"UNKNOWN","sponsor":"Duta Wacana Christian University","startDate":"2020-11-03","conditions":"Painful Diabetic Neuropathy","enrollment":60},{"nctId":"NCT03017430","phase":"PHASE4","title":"Pregabalin for Opiate Withdrawal Syndrome","status":"COMPLETED","sponsor":"St. Petersburg Bekhterev Research Psychoneurological Institute","startDate":"2014-01","conditions":"Opioid Withdrawal","enrollment":100},{"nctId":"NCT03618589","phase":"PHASE1","title":"Pregabalin add-on for Neuropathic Pain in Cervical Myelopathy","status":"UNKNOWN","sponsor":"Seoul National University Hospital","startDate":"2016-11-26","conditions":"Pain, Neuropathic","enrollment":60},{"nctId":"NCT02727101","phase":"PHASE4","title":"Perampanel for Treatment of Adults With Refractory Focal Epilepsy : a Pilot Study.","status":"TERMINATED","sponsor":"Mid-Atlantic Epilepsy and Sleep Center, LLC","startDate":"2015-11","conditions":"Epilepsy","enrollment":8},{"nctId":"NCT00787462","phase":"NA","title":"Evaluation of Pregabalin in Idiopathic Small Fiber Neuropathy","status":"TERMINATED","sponsor":"University of Alberta","startDate":"2008-02","conditions":"Small-Fiber Neuropathy","enrollment":3},{"nctId":"NCT02215252","phase":"PHASE2","title":"A Clinical Trial To Evaluate PF-05089771 On Its Own And As An Add-On Therapy To Pregabalin (Lyrica) For The Treatment Of Pain Due To Diabetic Peripheral Neuropathy (DPN)","status":"COMPLETED","sponsor":"Pfizer","startDate":"2014-11-10","conditions":"Diabetic Neuropathy, Painful","enrollment":141},{"nctId":"NCT02052414","phase":"NA","title":"Study of Gralise to Treat Fibromyalgia Patients","status":"COMPLETED","sponsor":"The Center for Clinical Research, Winston-Salem, NC","startDate":"2012-07","conditions":"Fibromyalgia","enrollment":34},{"nctId":"NCT00583869","phase":"EARLY_PHASE1","title":"Role of Pregabalin in Treatment of Post-Op Pain in Fracture Patients","status":"COMPLETED","sponsor":"University of Alabama at Birmingham","startDate":"2007-05","conditions":"Post-operative Pain","enrollment":86},{"nctId":"NCT02024568","phase":"PHASE2","title":"Exploratory Study on the Use of Pregabalin for the Treatment of Taxol Related Arthralgia-Myalgia","status":"UNKNOWN","sponsor":"Assaf-Harofeh Medical Center","startDate":"2013-12","conditions":"Taxane, Drug-related Side Effects and Adverse Reactions, Pain","enrollment":38},{"nctId":"NCT00643136","phase":"PHASE3","title":"A Study of Lyrica as Treatment for Sleep Problems in Patients With Sleep Problems and Seizures","status":"COMPLETED","sponsor":"Pfizer","startDate":"2002-11","conditions":"Sleep Deprivation, Epilepsies, Partial","enrollment":17}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":54,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Pregabalin add-on therapy","genericName":"Pregabalin add-on therapy","companyName":"Pfizer's Upjohn has merged with Mylan to form Viatris Inc.","companyId":"pfizer-s-upjohn-has-merged-with-mylan-to-form-viatris-inc","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Pregabalin binds to the alpha-2-delta subunit of voltage-gated calcium channels in the central nervous system, reducing the release of excitatory neurotransmitters. Used for Neuropathic pain (add-on therapy), Partial-onset seizures (add-on therapy), Generalized anxiety disorder (add-on therapy).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":1},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}